Área salud
Área salud
Área salud
Clinical and immune evolution in neurological/psychiatric patients during the COVID-19 pandemic
Introduction The COVID-19 pandemic has had a disastrous impact on the world’s population. Its effects were mainly respiratory, but resulting neurological damage has also been described. In this context, we evaluated the effects of COVID-19 […]
Área salud
Impact of COVID-19 on physiotherapy for patients with multiple sclerosis in Spain: Adaptation and challenges in the implementation of telerehabilitation
Introduction The COVID-19 pandemic, declared in March 2020, had a profound impact on health services in Spain, especially on physiotherapy for people with multiple sclerosis (PwMS). The health reorganization forced the suspension of rehabilitation services, […]
Área salud
Área salud
Functional cognitive disorder: Beyond pseudodementia
Introduction Many patients with cognitive symptoms, such as subjective memory complaints, may in fact have functional cognitive disorder. Development This review explores various aspects of functional cognitive disorder. We describe the clinical characteristics that support […]
Área salud
Survey on first-line therapeutic management of relapsing–remitting multiple sclerosis in clinical practice in Spain
Introduction Current therapies for relapsing–remitting multiple sclerosis (RRMS) help reduce morbidity and delay disease progression. However, the available information on factors influencing decision-making regarding first-line treatment remain poorly understood. Methods Based on a review of […]
Área salud
Ibero-American consensus statement on migraine treatment
Introduction and objectives Migraine is the most common reason for neurology outpatient consultation; more than 80% of patients with migraine suffer some degree of associated disability. Migraine is an underdiagnosed disorder and patients frequently receive […]
Área salud
Association of depression in multiple sclerosis with fatigue, sleep disturbances, disability, and health-related quality of life: Outcomes of a cross-sectional study
Introduction Depression affect individuals with multiple sclerosis (MS) more frequently compared with the general population. It can worsen the symptoms of MS, influence disability progression, and significantly reduce the quality of life (QoL). Method We […]